TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Taro Pharmaceuticals Case 08/02/2004

  • If you purchased a significant amount of shares of this company you have certain options and for certain investors are short and strict deadlines running. Investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

Company
Taro Pharmaceuticals
Security
OTC: TAROF

Case Name
Taro Pharmaceuticals Case 08/02/2004
Type of Lawsuit
Shareholder Class Action
Class Period Begin
Class Period End
You must register or login to receive notifications.

Click here to subscribe to Taro Pharmaceuticals.
Summary

<p>On Monday, April 28th, Taro Pharmaceuticals Ltd. announced, the same day a federal judge in the U.S. District Court for the Southern District of New York refused the company’s motion to dismiss the purported shareholder class action, that it had reached a settlement over a class action with the shareholders, who alleged the company that is sold excessive amounts of drugs in order to inflate its financial statements.</p>